留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

复方短效口服避孕药应用中不定期出血的管理

马淼 唐瑞怡 陈蓉

马淼, 唐瑞怡, 陈蓉. 复方短效口服避孕药应用中不定期出血的管理[J]. 协和医学杂志, 2020, 11(1): 73-78. doi: 10.3969/j.issn.1674-9081.20170182
引用本文: 马淼, 唐瑞怡, 陈蓉. 复方短效口服避孕药应用中不定期出血的管理[J]. 协和医学杂志, 2020, 11(1): 73-78. doi: 10.3969/j.issn.1674-9081.20170182
Miao MA, Rui-yi TANG, Rong CHEN. Management of Unscheduled Bleeding in Women Using Combined Oral Contraceptives[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 73-78. doi: 10.3969/j.issn.1674-9081.20170182
Citation: Miao MA, Rui-yi TANG, Rong CHEN. Management of Unscheduled Bleeding in Women Using Combined Oral Contraceptives[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 73-78. doi: 10.3969/j.issn.1674-9081.20170182

复方短效口服避孕药应用中不定期出血的管理

doi: 10.3969/j.issn.1674-9081.20170182
详细信息
    通讯作者:

    陈蓉 电话:010-69155012, E-mail:chenrongpumch@163.com

  • 中图分类号: R715.2

Management of Unscheduled Bleeding in Women Using Combined Oral Contraceptives

More Information
  • 摘要: 不定期出血是复方短效口服避孕药应用期间女性停药的常见原因。不定期出血的充分告知以及必要的预防和治疗, 能够提高女性口服避孕药的依从性。但目前关于不定期出血的机制尚不明确, 且缺乏高级别证据支持的有效预防和治疗方法。对于新发或持续性不定期出血妇女, 排除妇科疾病很重要。
    利益冲突  无
  • [1] 复方口服避孕药临床应用中国专家共识专家组.复方口服避孕药临床应用中国专家共识[J].中华妇产科杂志, 2015, 50:81-91. http://d.wanfangdata.com.cn/periodical/zhfck201502001
    [2] Maguire K, Westhoff C. The state of hormonal contraception today:established and emerging noncontraceptive health benefits[J]. Am J Obstet Gynecol, 2011, 205:S4-S8. doi:  10.1016/j.ajog.2011.06.056
    [3] 中华医学会妇产科学分会绝经学组.围绝经期异常子宫出血诊断和治疗专家共识[J].协和医学杂志, 2018, 9:313-319. http://oldmed.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_zhfck201806007
    [4] Shlomo M, Kenneth S, Polonsky P, et al. Williams Textbook of Endocrinology[M]. 13th ed. Amsterdam:Elsevier, 2015:664-693.
    [5] Reid RL, Fortier MP, Smith L, et al. Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada[J]. Contraception, 2010, 82:497-502. doi:  10.1016/j.contraception.2010.06.002
    [6] Mishell DR Jr, Guillebaud J, Westhoff C, et al. Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials[J]. Contraception, 2007, 75:11-15. doi:  10.1016/j.contraception.2006.08.012
    [7] Lumsden MA, Gebbie A, Holland C. Managing unscheduled bleeding in non-pregnant premenopausal women[J]. BMJ (Online), 2013, 346:f3251 https://www.bmj.com/content/346/bmj.f3251.full
    [8] Galant C, Berliere M, Dubois D, et al. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding[J]. Am J Pathol, 2004, 165:83-94. doi:  10.1016/S0002-9440(10)63277-4
    [9] Vincent AJ, Zhang J, Ostor A, et al. Matrix metalloproteinase-1 and-3 and mast cells are present in the endometrium of women using progestin-only contraceptives[J]. Hum Reprod, 2000, 15:123-130. doi:  10.1093/humrep/15.1.123
    [10] Hickey M, Fraser IS. Clinical implications of disturbances of uterine vascular morphology and function[J]. Baillieres Best Pract Res Clin Obstet Gynaecol, 2000, 14:937-951. doi:  10.1053/beog.2000.0136
    [11] Endrikat J, Gerlinger C, Plettig K, et al. A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive use[J]. Gynecol Endocrinol, 2003, 17:107-114. doi:  10.1080/gye.17.2.107.114
    [12] Dickinson BD, Altman RD, Nielsen NH, et al. Drug interactions between oral contraceptives and antibiotics[J]. Obstet Gynecol, 2001, 98:853-860.
    [13] Rosenberg MJ, Waugh MS, Stevens CM. Smoking and cycle control among oral contraceptive users[J]. Am J Obstet Gynecol, 1996, 174:628-632. doi:  10.1016/S0002-9378(96)70440-4
    [14] FSRH. Management of Unscheduled Bleeding in Women Using Hormonal Contraception[M/OL]. UK: Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit, 2009: 1-19. https://www.rcog.org.uk/globalassets/documents/guidelines/unscheduledbleeding23092009.pdf.
    [15] CDC. Sexually Transmitted Disease Surveillance 2016[M/OL]. US: Centers for Disease Control and Prevention, 2016.https://www.cdc.gov/std/stats16/CDC_2016_STDS_Report-for508WebSep21_2017_1644.pdf.
    [16] Chen XS, Peeling RW, Yin YP, et al. The epidemic of sexually transmitted infections in China:implications for control and future perspectives[J]. BMC Med, 2011, 9:111. doi:  10.1186/1741-7015-9-111
    [17] Speroff L, Darney PD. A Clinical Guide For Contraception[M].5th ed. US:Lippincott Williams & Wilkins, 2010.
    [18] Hickey M, Agarwal S. Unscheduled bleeding in combined oral contraceptive users:focus on extended-cycle and continuous-use regimens[J]. J Fam Plann Reprod Health Care, 2009, 35:245-248. doi:  10.1783/147118909789587411
    [19] Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC) US. Selected Practice Recommendations for Contraceptive Use, 2013:adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition[J]. MMWR Recomm Rep, 2013, 62:1-60.
    [20] Kaunitz A, Howard B, Weiss H, et al. Bleeding profile of a novel ascending-dose, extended-regimen ethinyl estradiol/levonorgestrel combination oral contraceptive (OC)[J]. Contraception, 2013, 88:311-312.
    [21] Gallo MF, Nanda K, Grimes DA, et al. 20μg versus >20μg estrogen combined oral contraceptives for contraception[J]. Cochrane Database Syst Rev, 2013, (8):CD003989.
    [22] Edelman AB, Koontz SL, Nichols MD, et al. Continuous oral contraceptives:are bleeding patterns dependent on the hormones given?[J]. Obstet Gynecol, 2006, 107:657-665. doi:  10.1097/01.AOG.0000199950.64545.16
    [23] Sulak PJ, Kuehl TJ, Coffee A, et al. Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen[J]. Am J Obstet Gynecol, 2006, 195:935-941. doi:  10.1016/j.ajog.2006.02.048
    [24] Kaneshiro B, Edelman A, Carlson N, et al. Treatment of unscheduled bleeding in continuous oral contraceptive users with doxycycline:a randomized controlled trial[J]. Obstet Gynecol, 2010, 115:1141-1149. doi:  10.1097/AOG.0b013e3181e0119c
    [25] Kaneshiro B, Edelman A, Carlson NE, et al. Unscheduled bleeding with continuous oral contraceptive pills:a compari-son of progestin dose[J]. Contraception, 2012, 86:22-27. doi:  10.1016/j.contraception.2011.11.003
    [26] Apter D, Zimmerman Y, Beekman L, et al. Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives:Results from a phase Ⅱ, randomised, dose-finding study (FIESTA)[J]. Contraception, 2016, 94:366-373. doi:  10.1016/j.contraception.2016.04.015
    [27] Lawrie TA, Helmerhorst FM, Maitra NK, et al. Types of progestogens in combined oral contraception:effectiveness and side-effects[J]. Cochrane Database Syst Rev, 2011, (5):CD004861.
    [28] Van Vliet HA, Grimes DA, Helmerhorst FM, et al. Bipha-sic versus monophasic oral contraceptives for contraception:a Cochrane review[J]. Hum Reprod, 2002, 17:870-873. doi:  10.1093/humrep/17.4.870
    [29] Van Vliet HA, Grimes DA, Helmerhorst FM, et al. Bipha-sic versus triphasic oral contraceptives for contraception[J]. Cochrane Database Syst Rev, 2006, (3):CD003283. https://www.ncbi.nlm.nih.gov/pubmed/12057781/
    [30] Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive[J]. Contraception, 2003, 68:89-96. doi:  10.1016/S0010-7824(03)00141-0
    [31] Wiegratz I, Stahlberg S, Manthey T, et al. Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy[J]. Contraception, 2011, 84:133-143. doi:  10.1016/j.contraception.2011.01.002
  • 加载中
计量
  • 文章访问数:  579
  • HTML全文浏览量:  29
  • PDF下载量:  159
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-08-25
  • 刊出日期:  2020-01-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!